logo
welcome
Guardian

Guardian

World-first lung cancer vaccine trials launched across seven countries

Guardian
Summary
Nutrition label

62% Informative

New jab instructs the body to hunt down and kill cancer cells then prevents them ever coming back.

Known as BNT116 and made by BioNTech, the vaccine is designed to treat non-small cell lung cancer ( NSCLC ), the most common form of the disease.

Janusz Racz , 67 , from London , was the first person to have the vaccine in the UK .

He received six consecutive injections five minutes apart over 30 minutes on Tuesday .

VR Score

61

Informative language

60

Neutral language

14

Article tone

informal

Language

English

Language complexity

46

Offensive language

not offensive

Hate speech

not hateful

Attention-grabbing headline

not detected

Known propaganda techniques

not detected

Time-value

short-lived

External references

no external sources

Source diversity

no sources

Affiliate links

no affiliate links